Abstract:Cytochrome P450 3A4 (CYP3A4), a key enzyme, is pivotal in metabolizing approximately half of the drugs used clinically. The genetic polymorphism of the CYP3A4 gene significantly influences individual variations in drug metabolism, potentially leading to severe adverse drug reactions (ADRs). In this study, we conducted a genetic analysis on CYP3A4 gene in 1163 Chinese Han individuals to identify the genetic variations that might affect their drug metabolism capabilities. For this purpose, a multiplex polymerase chain reaction (PCR) amplicon sequencing technique was developed, enabling us to perform the genotyping of CYP3A4 gene efficiently and economically on a large scale. As a result, a total of 14 CYP3A4 allelic variants were identified, comprising six previously reported alleles and eight new nonsynonymous variants that were nominated as new allelic variants *39–*46 by the PharmVar Association. Further, functional assessments of these novel CYP3A4 variants were undertaken by coexpressing them with cytochromes P450 oxidoreductase (CYPOR) in Saccharomyces cerevisiae microsomes. Immunoblot analysis indicated that with the exception of CYP3A4.40 and CYP3A4.45, the protein expression levels of most new variants were similar to that of the wild-type CYP3A4.1 in yeast cells. To evaluate their catalytic activities, midazolam was used as a probe drug. The results showed that variant CYP3A4.45 had almost no catalytic activity, whereas the other variants exhibited significantly reduced drug metabolism abilities. This suggests that the majority of the CYP3A4 variants identified in the Chinese population possess markedly altered capacities for drug metabolism. SIGNIFICANCE STATEMENT In this study, we established a multiplex polymerase chain reaction (PCR) amplicon sequencing method and detected the maximum number of new CYP3A4 variants in a single ethnic population. Additionally, we performed the functional characterizations of these eight novel CYP3A4 allele variants in vitro. This study not only contributes to the understanding of CYP3A4 genetic polymorphism in the Chinese Han population but also holds substantial reference value for their potential clinical applications in personalized medicine.

Effect of 24 Cytochrome P450 2D6 Variants Found in the Chinese Population on the N-demethylation of Amitriptyline in Vitro.

Identification and Functional Assessment of EightCYP3A4Allelic Variants39–46Detected in the Chinese Han Population

Effect of Cyp2d6 Genetic Polymorphism on the Metabolism of Citalopram in Vitro

Effect of 24 Cytochrome P450 2D6 Variants Found in the Chinese Population on Atomoxetine Metabolism in Vitro

Effect of CYP2D6 Variants on Venlafaxine Metabolism in Vitro

The Cytochrome P450 2D6 (CYP2D6) Enzyme Polymorphism: Screening Costs and Influence on Clinical Outcomes in Psychiatry

Effects of 31 Recombinant CYP2C19 Variants on Clomipramine Metabolism in Vitro

Effects of 22 Novel CYP2D6 Variants Found in Chinese Population on the Metabolism of Dapoxetine

In Vitro Functional Assessment of 22 Newly Identified CYP2D6 Allelic Variants in the Chinese Population.

In Vitro Functional Analysis of 24 Novel Cyp2c19 Variants Recently Found in the Chinese Han Population

Effect of 22 CYP2D6 variants found in the Chinese population on tolterodine metabolism in vitro

Effects of 22 Novel CYP2D6 Variants Found in the Chinese Population on the Bufuralol and Dextromethorphan Metabolisms in Vitro

Functional Characterization of 22 Novel Cyp2d6 Variants for the Metabolism of Tamoxifen

Effects of CYP2C19 variants on methadone metabolism in vitro.

Effects of CYP2C19 Variants on Fluoxetine Metabolism in Vitro.

Effects of 24 CYP2D6 Variants Found in the Chinese Population on the Metabolism of Risperidone.

In Vitro Functional Characterization of 37 CYP2C9 Allelic Isoforms Found in Chinese Han Population.

Functional characterization of 21 CYP3A4 variants on Amiodarone metabolism in vitro.

Estimation of CYP2D6*10 genotypes on citalopram disposition in Chinese subjects by population pharmacokinetic assay.

Clinical Pharmacogenetics Implementation Consortium Guideline for CYP2D6 and CYP2C19 Genotypes and Dosing of Tricyclic Antidepressants

Effects of 24 CYP2D6 Variants Found in Chinese Population on the Metabolism of Clonidine in Vitro